1,127 results on '"Raab, M"'
Search Results
2. Real-world analysis of teclistamab in 123 RRMM patients from Germany
3. Safe liquid scintillators for large scale detectors
4. Spontaneous grip force fluctuations mirror semantic numerical magnitude processing: Larger numbers elicit larger forces
5. Coexisting multi-states in catalytic hydrogen oxidation on rhodium
6. BRAF-Inhibitoren in der Therapie des multiplen Myeloms
7. CO Oxidation on Stepped Rh Surfaces: μm-Scale Versus Nanoscale
8. The ALMANACH Project: Preliminary results and potentiality from Afghanistan
9. Meeting report of the 7th Heidelberg Myeloma Workshop: today and tomorrow
10. Embodied Perspectives on Behavioral Cognitive Enhancement
11. Primärtherapie beim Multiplen Myelom
12. How to not induce SNAs: The insufficiency of directional force
13. A dissociable functional relevance of theta- and beta-band activities during complex sensorimotor integration
14. Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
15. TRACK: A new algorithm and open-source tool for the analysis of pursuit-tracking sensorimotor integration processes
16. The neurophysiology of continuous action monitoring
17. Forschungsinitiative Energiewende im Verkehr. Kurzbericht zur Roadmap für strombasierte Kraftstoffe
18. Roadmap für strombasierte Kraftstoffe. Gesamtbericht zur Begleitforschung Energiewende im Verkehr (BEniVer)
19. ESCRT III repairs nuclear envelope ruptures during cell migration to limit DNA damage and cell death
20. Conceptual MMV Outline: Illinois CarbonSafe Prairie Project
21. Cobimetinib alone and plus venetoclax with/without atezolizumab in patients with relapsed/refractory multiple myeloma
22. Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus
23. Homer1 (VesL-1) in the rat esophagus: focus on myenteric plexus and neuromuscular junction
24. Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma
25. Safe liquid scintillators for large scale detectors
26. A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM): INITIAL SAFETY RESULTS FOR MAGNETISMM-3
27. Micromanufactured electrodes for cortical field potential recording: in vivo study
28. E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271
29. Techno‐Economic and Environmental Assessment of Multiple Energy Transition Options – Methodology and Results
30. Micro- and macronutrient intake in myeloma patients correlates with clinical parameters: potential implications for supportive care
31. PB1983: TRIAL-IN-PROGRESS: PHASE II STUDY OF PHE885, A B-CELL MATURATION ANTIGEN-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN ADULTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
32. P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES AND UPDATED CLINICAL DATA
33. P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FROM THE GMMG-HD7 TRIAL
34. P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA
35. PB1976: CRISPR-CAS9 KNOCKOUT SCREEN IDENTIFIES RNA MODIFICATION ENZYMES ESSENTIAL FOR CELL SURVIVAL IN MULTIPLE MYELOMA
36. P926: DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE FOR TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND SEVERE RENAL IMPAIRMENT: RESULTS FROM THE PHASE 2 GMMG-DANTE TRIAL
37. P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR MAGNETISMM-3
38. Supermolecular Structure and Mechanical Behaviour of Isotactic Polypropylene
39. 147 Development of an Ultrasound Algorithm Enabled Handheld Automated Needle Decompression Device (ANeeD) for Pneumothorax Decompression in a Live Swine Model
40. Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma
41. Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma
42. Erratum zu: Primärtherapie beim Multiplen Myelom
43. Die seltene thorakale Manifestation eines extramedullären Myeloms
44. P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY
45. Übermolekulare Struktur und mechanische Eigenschaften von isotaktischem Polypropylen
46. Gleichstrom zur Behandlung maligner Weichteiltumoren im Tierexperiment
47. Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure
48. Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma
49. Localization of receptors for calcitonin-gene-related peptide to intraganglionic laminar endings of the mouse esophagus: peripheral interaction between vagal and spinal afferents?
50. Strategien beim rezidivierten/refraktären multiplen Myelom
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.